According to our data set, three genes, EZH2, GRPEL2, and NDRG1, and one clinical factor, tumor size, could be used as reliable indicators for evaluating the prognosis in patients with HCC. The gene discussed is GRPEL2; the disease is hepatocellular carcinoma.